| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851792 | American Journal of Kidney Diseases | 2008 | 9 Pages |
Abstract
The observed mortality risk estimates associated with EPO dose in nonexperimental studies in dialysis patients may be highly sensitive to the analytic method used. This highlights the complexity of evaluating the association between EPO dose, Hb level, and mortality in these studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Brian D. DSc, Ouhong PhD, Cathy W. PhD, Kenneth J. DrPH, Patrick PhD, Marcia PhD, John F. PhD,